Africa’s pharmaceutical sector is witnessing an influx of foreign interest, with Chinese companies leading the charge. This ...

Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S.

Shares of major European drugmakers fell Wednesday morning after U.S. President Donald Trump reaffirmed plans to impose a ...

UCB Pharma Inc. has presented new preclinical data on their anti-α-synuclein antibody UCB-7853 for the potential treatment of PD.

DMW has received consulting fees from Alexion, Roche, Genentech, Horizon Therapeutics, Imcyse, Bristol Myers Squibb and Reistone, serves on an attack adjudication committee for a MOGAD clinical trial ...

24 scientific abstracts reflect UCB's ongoing commitment to improving outcomes for people living with neurological conditions, including rare epilepsies Dravet syndrome and Lennox-Gastaut syndrome ...

Tuesday, UBS increased its stock price target on UCB (UCB:BB) (OTC: UCBJY) to EUR135.00 from EUR125.00, while keeping a Buy rating ...

Union Bancaire Privee UBP SA bought a new position in shares of Aurinia Pharmaceuticals in the 4th quarter valued at $108,000. Finally, Cibc World Markets Corp acquired a new position in shares of ...

Investing.com – Belgium stocks were higher after the close on Monday, as gains in the Healthcare, Utilities and Banking sectors ...

BIASCA, Switzerland, March 31, 2025 /PRNewswire/ -- HAS Healthcare Advanced Synthesis SA ("HAS"), a leading international developer and producer of active pharmaceutical ingredients (APIs), ...